Jennifer Chu, MD | UniHealth

Offices

2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chu’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A166458 · Current

Licensed to practise in California · since 2019 · expires 2027-10-31 · Tufts University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025

See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Peninsula Medical Center

Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.139	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.242	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.21 (0.27 to 2.15) · 1,258 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.81 (0.51 to 1.1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	155.44 (112.67 to 198.21) · 90 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.5 · 32 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.1 · 82 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10 · 188 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9 · 473 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	14.8 · 342 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.4 · 485 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.9 · 3,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.2 (0 to 0.4) · 6,904 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.21 (0.02 to 0.4) · 7,052 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.41 (1.43 to 5.39) · 1,695 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.72 (0.17 to 3.28) · 665 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.11 (0.66 to 3.56) · 1,545 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	7.1 (1.3 to 12.9) · 670 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.96 (2.63 to 9.29) · 653 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.61 (0.15 to 3.08) · 418 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.14 (0 to 0.78) · 5,539 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.7 · 192 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.215	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.263	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.74	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.3 · 300 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19 · 702 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	1.2 · 207 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-13.6 · 531 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	24.3 · 343 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	18.1 · 449 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	4.5 (2.8 to 7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	9.6 (6.7 to 13.7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.7 · 189 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	11 · 45 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.6 · 117 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13 (9.7 to 17.2) · 584 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.7 to 1.2) · 764 cases	No different	Jan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Sort by

Patient survey stars by topic at Peninsula Medical Center

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	3
Recommend hospital	5

Sort by

Share of patients giving the best answer at Peninsula Medical Center

Room was "always" clean	76%
Nurses "always" communicated well	81%
Doctors "always" communicated well	80%
Staff "always" explained	58%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	87%
Doctors "always" explained things so they could understand	74%
Doctors "always" listened carefully	79%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	75%
Staff "always" explained new medications	72%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	54%
"YES", patients would definitely recommend the hospital	78%
Staff "always" explained possible side effects	44%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$82,156

Medicare paid this office $82,156 for 330 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	195	$35,874	$103
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	64	$12,011	$67
New patient visit (45+ min)	77	$10,727	$139
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	14	$7,137	$105
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	193	$4,258	$14

See all 11 services

Sort by

Every Original Medicare service billed

Return visit (30+ min)	195	$35,874	$103
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	64	$12,011	$67
New patient visit (45+ min)	77	$10,727	$139
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	14	$7,137	$105
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	193	$4,258	$14
Long return visit (40+ min)	17	$3,141	$157
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	43	$2,652	$29
New patient visit (60+ min)	11	$1,893	$172
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes	24	$1,800	$72
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes	14	$518	$37
Hemoglobin a1c level	14	$133	$10

Who their Medicare patients are

330 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 13% · Women 61% · Also on Medicaid 11% · Health risk score 1.42. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 75% · Diabetes 57% · Chronic kidney disease 40% · Coronary heart disease 29% · Heart failure 22% · Atrial fibrillation 22% · Cancer 16% · Depression 16% · COPD 13% · Stroke 7% · Dementia 6%.

The office billed $317,598, Medicare allowed $114,099 and paid $82,156; for 1,164 services of 17 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	330	1,164	75	1.42	$317,598	$82,156
2023	282	877	75	1.48	$264,589	$72,911
2022	282	861	75	1.63	$259,950	$74,388
2021	225	760	74	1.85	$228,558	$70,001
2020	207	722	74	2.14	$171,636	$55,789
2019	17	28	75	3.28	$7,702	$2,312

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	172	$35,320	$109
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	60	$14,293	$68
New patient visit (45+ min)	59	$8,332	$141
Long return visit (40+ min)	24	$3,408	$131
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes	36	$2,584	$68
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	31	$2,083	$29
Hemoglobin a1c level	66	$1,028	$10

2022: 9 services

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	158	$32,826	$111
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	61	$9,565	$61
New patient visit (45+ min)	51	$6,868	$135
Long return visit (40+ min)	38	$6,638	$144
New patient visit (60+ min)	32	$5,634	$176
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes	33	$3,345	$88
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	30	$2,026	$31
Telephone medical discussion with physician, 21-30 minutes	11	$1,295	$108
Hemoglobin a1c level	68	$1,035	$10

2021: 12 services

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	109	$26,438	$113
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	64	$12,696	$64
New patient visit (45+ min)	50	$7,023	$140
Long return visit (40+ min)	31	$5,469	$152
New patient visit (60+ min)	23	$4,378	$190
Telephone medical discussion with physician, 21-30 minutes	16	$2,863	$106
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes	20	$2,012	$87
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	16	$1,940	$121
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	24	$1,623	$31
Telephone medical discussion with physician, 11-20 minutes	14	$1,104	$65
Telephone medical discussion with physician, 5-10 minutes	13	$534	$38
Hemoglobin a1c level	32	$350	$10

2020: 10 services

Sort by

Original Medicare services billed in 2020

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	60	$14,173	$65
Return visit (30+ min)	69	$13,152	$100
New patient visit (45+ min)	48	$7,118	$148
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes	42	$4,010	$91
Telephone medical discussion with physician, 11-20 minutes	39	$3,441	$67
Telephone medical discussion with physician, 21-30 minutes	21	$2,782	$99
Long return visit (40+ min)	13	$2,200	$137
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	25	$1,829	$33
Telephone medical discussion with physician, 5-10 minutes	12	$1,259	$23
Telephone medical discussion with physician, 5-10 minutes	19	$1,018	$44

Medicaid work

$2,684 in 2023

Medicaid paid $2,684 for 99 billed services this clinician did in 2023, up to 19 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2023

SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	99	$2,684

Sort by

Medicaid work by year

2023	99	1	19	$2,684
2021	25	1	12	$819

See the largest Medicaid services in earlier years

2021

Sort by

Largest Medicaid services in 2021

SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	25	$819

Drugs they prescribed that Part D paid

$964,459

Pharmacies billed $964,459 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,060) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

941 generic and 948 brand-name prescriptions · $964,459 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ozempic	178	$266,488	$1,497
Trulicity	99	$188,323	$1,902
Jardiance	99	$122,947	$1,242
Rybelsus	58	$65,634	$1,132
Mounjaro	39	$58,898	$1,510

See all 38 drugs

Sort by

Every Part D drug this clinician prescribed

Ozempic	178	$266,488	$1,497
Trulicity	99	$188,323	$1,902
Jardiance	99	$122,947	$1,242
Rybelsus	58	$65,634	$1,132
Mounjaro	39	$58,898	$1,510
Januvia	39	$33,579	$861
Fiasp Flextouch	19	$24,125	$1,270
Farxiga	16	$19,051	$1,191
Humalog Kwikpen U-100	28	$13,148	$470
Basaglar Kwikpen U-100	26	$13,055	$502
Teriparatide	13	$13,000	$1,000
Tresiba Flextouch U-100	20	$12,848	$642
Lantus Solostar	93	$12,698	$137
Nano 2nd Gen Pen Needle	63	$8,217	$130
Insulin Lispro Kwikpen U-100	12	$5,915	$493
Novolog Flexpen	15	$5,427	$362
Ultra-Fine Mini Pen Needle	50	$4,505	$90
Insulin Glargine-Yfgn	17	$2,692	$158
Metformin Hcl Er	123	$2,444	$20
Repaglinide	45	$1,953	$43
Ultra-Fine Short Pen Needle	21	$1,949	$93
Synthroid	16	$1,745	$109
Alendronate	166	$1,682	$10
Risedronate	11	$1,565	$142
Levothyroxine	121	$1,452	$12
Atorvastatin	80	$1,129	$14
Metformin	99	$968	$10
Ezetimibe	23	$708	$31
Ibandronate	17	$670	$39
Glipizide Er	46	$668	$15
Ultra-Fine Nano Pen Needle	13	$643	$49
Rosuvastatin	19	$417	$22
Methimazole	31	$394	$13
Gabapentin	16	$302	$19
Glipizide	26	$260	$10
Hydrocortisone	12	$257	$21
Pioglitazone	16	$123	$8
Prednisone	16	$91	$6

Year by year

Sort by

Part D prescribing by year

2024	2,060	332	0% (0)	46%	$964,459
2023	1,944	304	0% (0)	48%	$1,110,988
2022	1,852	265	0% (0)	56%	$937,732
2021	1,488	261	0% (0)	55%	$814,141
2020	816	187	0% (0)	56%	$417,817
2019	91	20	0% (0)	56%	$27,393
2018	49	19	0% (0)	None	$4,362
2017	240	27	0% (0)	16%	$5,084
2016	192	43	None	17%	$7,060
2015	147	57	None	None	$8,958
2014	89	36	None	12%	$3,559
2013	15	None	None	None	$320

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 36 drugs

Sort by

Part D drugs prescribed in 2023

Trulicity	182	$326,377	$1,793
Ozempic	85	$146,712	$1,726
Jardiance	91	$108,786	$1,195
Lantus Solostar	136	$99,810	$734
Januvia	60	$48,733	$812
Humalog Kwikpen U-100	19	$39,690	$2,089
Mounjaro	23	$36,835	$1,602
Farxiga	17	$23,333	$1,373
Novolog Flexpen	15	$18,842	$1,256
Basaglar Kwikpen U-100	25	$13,559	$542
Tresiba Flextouch U-100	13	$9,045	$696
Omnipod Dash Pods (Gen 4)	13	$7,729	$595
Nano 2nd Gen Pen Needle	53	$7,334	$138
Insulin Lispro Kwikpen U-100	16	$6,574	$411
Nateglinide	31	$4,945	$160
Ultra-Fine Mini Pen Needle	38	$3,064	$81
Insulin Glargine-Yfgn	13	$2,832	$218
Levothyroxine	118	$2,552	$22
Alendronate	163	$2,313	$14
Metformin Hcl Er	99	$2,136	$22
Ultra-Fine Short Pen Needle	23	$2,050	$89
Ibandronate	18	$1,678	$93
Synthroid	16	$1,664	$104
Atorvastatin	61	$1,625	$27
Ultra-Fine Nano Pen Needle	11	$1,269	$115
Metformin	86	$1,168	$14
Gabapentin	26	$906	$35
Glipizide Er	44	$865	$20
Rosuvastatin	12	$607	$51
Hydrocortisone	13	$550	$42
Methimazole	21	$400	$19
Glipizide	26	$395	$15
Liothyronine	16	$330	$21
Pioglitazone	13	$327	$25
Losartan	23	$297	$13
Lisinopril	12	$111	$9

2022: 33 drugs

Sort by

Part D drugs prescribed in 2022

Trulicity	272	$349,615	$1,285
Jardiance	113	$86,073	$762
Lantus Solostar	122	$82,672	$678
Ozempic	67	$69,739	$1,041
Januvia	68	$51,958	$764
Humalog Kwikpen U-100	26	$51,230	$1,970
Novolog Flexpen	16	$19,820	$1,239
Victoza 2-Pak	18	$16,845	$936
Farxiga	24	$16,409	$684
Tradjenta	21	$12,541	$597
Fiasp Flextouch	11	$8,687	$790
Basaglar Kwikpen U-100	16	$7,900	$494
Insulin Lispro Kwikpen U-100	15	$7,311	$487
Nano 2nd Gen Pen Needle	51	$5,051	$99
Admelog Solostar	15	$5,048	$337
Ultra-Fine Short Pen Needle	31	$2,536	$82
Synthroid	26	$1,907	$73
Levothyroxine	106	$1,799	$17
Alendronate	136	$1,544	$11
Ultra-Fine Mini Pen Needle	23	$1,404	$61
Metformin Hcl Er	86	$1,301	$15
Atorvastatin	63	$1,297	$21
Ibandronate	15	$1,291	$86
Metformin	69	$872	$13
Gabapentin	24	$748	$31
Cytomel	11	$722	$66
Pioglitazone	13	$416	$32
Glipizide	21	$409	$19
Rosuvastatin	11	$379	$34
Ezetimibe	11	$337	$31
Glipizide Er	22	$320	$15
Methimazole	16	$256	$16
Lisinopril	20	$59	$3

2021: 26 drugs

Sort by

Part D drugs prescribed in 2021

Trulicity	283	$309,903	$1,095
Jardiance	88	$88,755	$1,009
Lantus Solostar	92	$54,721	$595
Januvia	50	$48,801	$976
Humalog Kwikpen U-100	27	$38,315	$1,419
Novolog Flexpen	24	$26,815	$1,117
Rybelsus	18	$15,941	$886
Ozempic	12	$10,874	$906
Tradjenta	18	$9,790	$544
Basaglar Kwikpen U-100	18	$7,623	$423
Nano 2nd Gen Pen Needle	21	$2,216	$106
Ultra-Fine Short Pen Needle	31	$2,161	$70
Synthroid	29	$1,828	$63
Pioglitazone	69	$1,794	$26
Ultra-Fine Mini Pen Needle	30	$1,693	$56
Metformin Hcl Er	60	$1,422	$24
Levothyroxine	56	$1,195	$21
Alendronate	63	$832	$13
Metformin	46	$751	$16
Atorvastatin	58	$653	$11
Acarbose	13	$482	$37
Glipizide Er	19	$346	$18
Gabapentin	24	$301	$13
Glipizide	17	$220	$13
Amlodipine Besylate	16	$191	$12
Lisinopril	27	$162	$6

2020: 21 drugs

Sort by

Part D drugs prescribed in 2020

Trulicity	85	$94,183	$1,108
Forteo	15	$64,067	$4,271
Jardiance	69	$50,068	$726
Januvia	36	$34,682	$963
Lantus Solostar	63	$30,192	$479
Humalog Kwikpen U-100	29	$25,188	$869
Novolog Flexpen	20	$21,050	$1,052
Ozempic	11	$12,726	$1,157
Basaglar Kwikpen U-100	12	$5,730	$477
Ultra-Fine Nano Pen Needle	25	$2,071	$83
Pioglitazone	53	$1,341	$25
Synthroid	19	$1,210	$64
Levothyroxine	41	$1,149	$28
Ultra-Fine Mini Pen Needle	19	$869	$46
Hydrocortisone	21	$573	$27
Metformin	30	$459	$15
Alendronate	18	$364	$20
Metformin Hcl Er	23	$350	$15
Methimazole	16	$304	$19
Glipizide	19	$183	$10
Atorvastatin	14	$165	$12

2019: 2 drugs

Sort by

Part D drugs prescribed in 2019

Jardiance	12	$9,709	$809
Ozempic	12	$9,189	$766

2017: 4 drugs

Sort by

Part D drugs prescribed in 2017

Metoprolol	51	$748	$15
Clopidogrel	53	$473	$9
Atorvastatin	31	$383	$12
Lisinopril	28	$103	$4

2016: 5 drugs

Sort by

Part D drugs prescribed in 2016

Atorvastatin	25	$411	$16
Metoprolol	20	$373	$19
Clopidogrel	28	$305	$11
Lisinopril	20	$70	$4
Citalopram Hbr	14	$57	$4

2014: 1 drug

Sort by

Part D drugs prescribed in 2014

Atorvastatin	15	$175	$12

Money from drug and device companies

$21 in 2025

Sort by

Industry payments by year

2025	1	1	None	$21
2019	2	3	None	$916

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Dexcom	Dexcom G6 Transmitter	$21	1 payment Meals for Dexcom G6 Transmitter · 2025-06-24 · $21

See the published payment

Sort by

Every published payment

Dexcom	Meals · 2025-06-24	Dexcom G6 Transmitter	$21

See earlier years (2019)

2019: $916

Sort by

Payments by company in 2019

Pfizer	Somavert	$826	2 payments Meals for Somavert · 2019-03-22 · $76 Grant · 2019-03-20 · $750
Novo Nordisk	None	$90	1 payment Meals · 2019-03-20 · $90

Professional record

NPI: 1760829493
Licence: CA A166458, MA 256270California A166458: Current · expires 2027-10-31
Group: Sutter Bay Medical Foundation
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
Mailing address: 325 Distel Cir, Los Altos, CA, 94022
NPI first listed: 2013-06-04
NPI last updated: 2020-06-04
NPI record certified: 2020-06-04

This is when the NPI record was last certified, not a medical board exam.